QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Quality-adjusted time without symptoms or toxicity (Q-TWiST) of patients with metastatic colorectal cancer (mCRC) treated with fruquintinib in a phase II clinical trial. 会议论文 作者:  Li, Jin;  Xu, Ruihua;  Bai, Yuxian;  Xu, Jianming;  Liu, Tianshu 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 A phase II study of Chinese patients (pts) treated with nab-paclitaxel (nab-P) plus gemcitabine (Gem) for metastatic pancreatic cancer (MPC) 会议论文 作者:  Shen, Lin;  Yu, Xianjun;  Hao, Jihui;  Wang, Liwei;  Pan, Hongming 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05 The Chinese subgroup from a randomized phase III study of lapatinib in combination with weekly paclitaxel versus weekly paclitaxel alone as second-line treatment of HER2-amplified advanced gastric cancer (AGC) in Asian countries 会议论文 作者:  Sun, Guo-ping;  Sun, Yan;  Xu, Rui-hua;  Xu, Jian-Ming;  Li, Jin 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19 The Chinese subgroup from a randomized phase III study of lapatinib in combination with weekly paclitaxel versus weekly paclitaxel alone as second-line treatment of HER2-amplified advanced gastric cancer (AGC) in Asian countries 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2013-05-20 作者:  Sun, Guo-ping;  Sun, Yan;  Xu, Rui-hua;  Xu, Jian-Ming;  Li, Jin 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/13